Rocca Family Vineyards hosts mobile COVID-19 testing in the parking lot.
N3 Laboratories is proud to offer Serology (Antibody) testing for COVID-19
CEO and Founder of Neurovations Dr. Eric Grigsby and Chief Medical Officer of Setpoint Dr. David Chernoff met for an in-depth discussion on the activation of neuroimmune reflexes by Vagus […]
CEO and Founder of Neurovations, Dr. Eric Grigsby joined Professor and Director of Neuromodulation Services at UCSF, Dr. Lawrence Poree, for an in-depth conversation on equity and inclusion in pain management.
Effectiveness and Safety of Intrathecal Ziconotide: Final Results of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)
The Patient Registry of Intrathecal Ziconotide Management evaluated the long-term effectiveness and safety of intrathecal ziconotide.
CEO and Founder of Neurovations and Eric J. Grigsby, MD, MBA and Peter Staats, MD, MBA met recently for a conversation exploring Neuromodulation for the COVID-19 Cytokine Storm.
Fact: There is low-quality evidence that a single intraarticular corticosteroid injection may increase the risk of contracting the influenza virus.
Download the resources to the webinar and map your future for pain procedures.
How to stay afloat as an independent medical practice during COVID-19 Download the Resources Here Join CalSIPP Board Members Eric J. Grigsby, MD, MBA, and Ruben Kalra, MD, MBA for […]
Brief Updates on Topics for Pain Management
Napa Pain Institute News provides updates on topics for Pain Management.
Read the recently published controlled trial comparing dorsal root ganglion (DRG) stimulation to spinal cord stimulation, showed that DRG stimulation is a safe and effective therapy in individuals with lower […]